Yamada, Yasuhiro

Premature Termination of Reprogramming In Vivo Leads to Cancer Development through Altered Epigenetic Regulation

Ohnishi, K., Semi, K., Yamamoto, T., Shimizu, M., Tanaka, A., Mitsunaga, K., Okita, K., Osafune, K., Arioka, Y., Maeda, T., et al. (2014) · Cell

Pluripotent Stem Cells ResearchEpigenetics and DNA Methylation

Cited by 460

Generation of a p16 Reporter Mouse and Its Use to Characterize and Target p16high Cells In Vivo

Omori, S., Wang, T.-W., Johmura, Y., Kanai, T., Nakano, Y., Kido, T., Susaki, E. A., Nakajima, T., Shichino, S., Ueha, S., et al. (2020) · Cell Metabolism

Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model Organisms

Cited by 194

In vivo reprogramming drives Kras-induced cancer development

Shibata, H., Komura, S., Yamada, Y., Sankoda, N., Tanaka, A., Ukai, T., Kabata, M., Sakurai, S., Kuze, B., Woltjen, K., et al. (2018) · Nature Communications

Pancreatic and Hepatic Oncology ResearchCancer Cells and Metastasis

Cited by 76

DMRT1-mediated reprogramming drives development of cancer resembling human germ cell tumors with features of totipotency

Taguchi, J., Shibata, H., Kabata, M., Kato, M., Fukuda, K., Tanaka, A., Ohta, S., Ukai, T., Mitsunaga, K., Yamada, Y., et al. (2021) · Nature Communications

Pluripotent Stem Cells ResearchGenetic Syndromes and Imprinting

Cited by 46